文献
J-GLOBAL ID:201202208117447186
整理番号:12A0906790
trastuzumab emtansine(T-DM1)の臨床薬理学:HER2陽性癌の治療の発展における抗体-薬物複合体
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer
著者 (15件):
GIRISH Sandhya
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
GUPTA Manish
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
GUPTA Manish
(Bristol-Myers Squibb, Lawrenceville, NJ, USA)
,
WANG Bei
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
LU Dan
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
KROP Ian E.
(Dana-Farber Cancer Inst., Boston, MA, USA)
,
VOGEL Charles L.
(Sylvester Comprehensive Cancer Center, Deerfield Beach, FL, USA)
,
BURRIS III Howard A.
(Sarah Cannon Res. Inst., Nashville, TN, USA)
,
LORUSSO Patricia M.
(Karmanos Cancer Center, Detroit, MI, USA)
,
YI Joo-Hee
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
SAAD Ola
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
TONG Barbara
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
CHU Yu-Waye
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
HOLDEN Scott
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
,
JOSHI Amita
(Genentech, Inc, 1 DNA Way, 94080, South San Francisco, CA, USA)
資料名:
Cancer Chemotherapy and Pharmacology
(Cancer Chemotherapy and Pharmacology)
巻:
69
号:
5
ページ:
1229-1240
発行年:
2012年05月
JST資料番号:
D0065D
ISSN:
0344-5704
CODEN:
CCPHDZ
資料種別:
逐次刊行物 (A)
発行国:
ドイツ (DEU)
言語:
英語 (EN)